Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Tracy Anne Burns has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12748426

PHARMACEUTICAL AEROSOL PRODUCT FOR ADMINISTRATION BY ORAL OR NASAL INHALATION

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/57, A61K 47/10
Applicant:
AstraZeneca AB
Applicant:
Takeda GmbH
Agent:
Tracy Anne Burns, AstraZeneca PLC
Agent:
Olaf Wrobel, Takeda GmbH
Status:
GRANT OF PATENT INTENDED
EP14170807

Pharmaceutical compositions comprising a HMG COA reductase inhibitor

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/26, A61K 9/32, A61K 31/505
Applicant:
AstraZeneca AB
Agent:
Tracy Anne Burns, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14164018

3,4,4a,10b-tetrahydro-1H-thiopyrano-[4,3-c]isoquinoline derivatives

IPC classification:
A61K 31/519, A61P 11/00, A61P 11/06, A61P 11/08, C07D 519/00
Applicant:
AstraZeneca AB
Applicant:
Takeda GmbH
Agent:
Tracy Anne Burns, AstraZeneca PLC
Agent:
Robert Wild, Takeda GmbH
Status:
PATENT GRANTED
EP15166135

SOLUBLE DOSAGE FORMS CONTAINING CEPHEM DERIVATIVES SUITABLE FOR PARENTERAL ADMINISTRATION

IPC classification:
A61K 31/546, A61P 31/04
Applicant:
AstraZeneca AB
Agent:
Tracy Anne Burns, AstraZeneca PLC
Agent:
Pfizer Inc
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature